Country: United Kingdom
Language: English
Source: HMA (Heads of Medicines Agencies)
tau-fluvalinate 11.84 %
VITA (Europe) Limited
QP53AC10
Bee-hive strip
fluvalinate
Bees
2011-07-14
Revised: August 2011 AN: 02140/2010 Page 1 of 4 SUMMARY OF PRODUCTS CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Apistan 10.3% w/w bee hive strip [UK] Apistan vet 10.3% w/w bee hive strip [SE] 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance mg/strip Tau fluvalinate 824 For a full list of excipients, please see section 6.1. 3. PHARMACEUTICAL FORM Bee hive strip 8g polymer strip measuring approximately 25 x 3 x 0.075 cm. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES The honeybee, _Apis mellifera _ 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Control of varroosis (_Varroa destructor_ (formerly known as _Varroa jacobsoni)_) in honeybee colonies 4.3 CONTRAINDICATIONS None known 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None 4.5 SPECIAL PRECAUTIONS FOR USE I. SPECIAL PRECAUTIONS FOR USE IN ANIMALS If signs of disease appear or persist then consult your veterinary surgeon. II. SPECIAL PRECAUTIONS FOR THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Avoid contact with skin, mouth and eyes. Wear gloves when handling strips. Wash hands thoroughly after handling strips. Do not smoke, drink or eat during application. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) None 4.7 USE DURING PREGNANCY, LACTATION OR LAY Not applicable 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None known Revised: August 2011 AN: 02140/2010 Page 2 of 4 4.9 AMOUNT(S) TO BE ADMINISTERED AND ADMINISTRATION ROUTE _Dose: _ 2 Apistan strips per brood chamber per beehive. _ _ _Administration: _ Strips are suspended mid-way between th Read the complete document